News

Dr.Yang Weiqin have been awarded the NSFC Young Scientists Fund 2024. SHe will receive funding of RMB 300,000 to support her research projects entitled:Delineating the Role and Mechanism of T cell-intrinsic HDAC8 Signaling in Non-alcoholic Fatty Liver Disease-related Liver Cancer.

Our lab members recently participated in The 11th International Symposium on 3D Genomics. Prof. Cheng delivered an insightful presentation on “Role of Epigenomic Reprogramming in Immunotherapy Resistance of Hepatocellular Carcinoma,” sharing the lab’s latest findings in cancer research.

Several members of our lab, including Prof. Alfred, Zhixian, Weiqin, Jing, and Yiling, attended the Japanese Cancer Association (JCA) 2024 conference held in Fukuoka.

As the summer comes to an end, we bid farewell to our talented interns, Zara and Chung-yan. Your hard work and dedication have made a significant impact on our team! Thank you for your contributions, and we wish you a bright future ahead!

Prof. Alfred Cheng was invited to attend a regular seminar on July 23, held by the Gilo Foundation Research Institute in Seoul.

Prof. Alfred Cheng was invited as a speaker and panelist at the APPLE Academy 2024, scheduled to take place on July 18, 2024, in Honolulu, Hawaii.

On 4 July 2024, Prof. Alfred S.L. Cheng, Professor of the School of Biomedical Sciences at The Chinese University of Hong Kong (CUHK), took part in an enriching event titled “Meeting with CUHK Professors,” organized by the CUHKFAA Chan Chun Ha Secondary School.

Prof. Alfred Cheng, alongside team members Patrick, Lingyun, and Yalin, represented our laboratory at the prestigious 2024 AACR Annual Meeting. Held from April 5th to 10th at the San Diego Convention Center, this gathering is a cornerstone event organized by the American Association for Cancer Research (AACR).

We are delighted to announce that Yingnan Lin has joined our laboratory as a research assistant, bringing his expertise to our ongoing exploration of the 3D genome. Yingnan will be an integral part of our team, focusing on 3D genome methodology and unraveling the intricacies of genome organization and its impact on gene regulation. His contributions will help us further our understanding of the spatial configuration of the genome and its role in cellular processes.

We’re excited to announce that Dr. Wang Jing has received the Best Poster Award at The Hong Kong Society for Immunology Annual Congress 2023/24. This recognition was given for her outstanding abstract, highlighting her exceptional research contributions.

Dr. Wang Jing has been selected as an oral presenter at the 1st HKU-CUHK Joint Postdoctoral Biomedical Sciences Symposium. The event will be held on 22 March 2024 at the Li Ka Shing Faculty of Medicine, University of Hong Kong. This prestigious opportunity highlights her outstanding research and dedication. We’re proud of her achievement and look forward to her presentation!

Cheng’s lab gathered at Chung Chi College Staff Canteen on Feb 26,2024 to celebrate the beginning of a new year together. Filled with laughter, conversations, and delectable food, the event provided an opportunity for team members to strengthen bonds and foster a sense of unity.

Organised by the Beijing-Hong Kong Academic Exchange Centre, the annual selection invites universities in Hong Kong to submit news on innovation, technology and scientific research. On 5 February, four CUHK research projects were named among the top ten Hong Kong Innovation and Technology News 2023.

Prof. Alfred S.L. Cheng, Professor, Dr. Ann S.N. Lau, Associate Director (Undergraduate Education) and Dr. Christopher Y.H. See, Lecturer of the School of Biomedical Sciences were invited as the speakers and moderator at the Faculty Strategic Workshop 2024 organised by the Faculty of Medicine of CUHK held on 27 Jan 2024 at the CUHK Medical Centre.

It is with mixed emotions that we bid farewell to Dr. Xiong Zhewen, a remarkable member of our lab, as she embarks on an exciting new chapter in her academic career at Stanford University.

We expressed heartfelt appreciation for Willis’s significant efforts and extended their best wishes as he embarks on his journey to become a veterinarian!

Tis the season to be jolly! Dec. 21 2023, Prof. Cheng, Prof. Zhou and Prof. Tong’s lab gathered together to exchange presents, expressing appreciation and strengthening the bonds that make our team thrive. This beloved annual tradition brings together lab members in a joyous celebration, fostering a sense of camaraderie, gratitude, and goodwill.

The Research Grants Council of Hong Kong (RGC) recently announced the funding results of the National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme (JRS) and Collaborative Research Scheme (CRS). The JRS is funding 10 projects at The Chinese University of Hong Kong (CUHK), while the CRS is funding two. Among the eight University Grants Committee (UGC)-funded universities, CUHK is the leader in the number of projects funded by the JRS and the total number funded by both schemes.

CUHK Emeritus Professor CHO Chi Hin, the Honorary Director of South Sichuan Institute of Translational Medicine (SSITM), along with Prof. CHAN Leung Franky and Prof. CHENG Sze-lok Alfred from CUHK SBS and other experts, visited the SSITM in November 2023.

We are delighted to extend our warmest congratulations to Dr. Liang Zhixian and Dr. Chen Shufen on their successful graduation. Their remarkable achievements and dedication have been truly inspiring, and we are immensely proud to have been a part of their academic journey.

Lab members Dr. Yang Weiqin, Dr. Tu Yalin, with Prof. Alfred Cheng recently attended the 82nd Annual Meeting of the Japan Cancer Association, held at Pacifico Yokohama from September 21st to September 23rd.

The new semester has begun and we are thrilled to welcome our new lab members! We are looking forward to working with them on exciting projects and discoveries that will advance our field.

After three years of fruitful collaboration, our lab bids farewell to Dr. Zhong Chengpeng, a visiting scholar from the Renji hospital affiliated to Shanghai Jiao Tong University School of Medicine.

中文大學醫學院破解肝癌的免疫耐藥機制，再配合新的免疫療法，能有效消除癌細胞。

Liver cancer remains one of the most common cancers in the world. Recent research from CUHK’s Faculty of Medicine has discovered how liver cancer cells adapt to immunotherapy, the most advanced therapy for cancer patients.

Welcome our summer research interns, Michelle and Sunnie! They will contribute to our project “Characterization of novel immuno-oncology drug candidates for cancer immunotherapy” and experience biomedical research in a practical and hands-on environment.

We are happy to have Prof. WANG Jia and his team for a visit and academic communication. We organized a Joint CUHK-GZHMU Lab Meeting on 3D Genome on 28th April.

Prof. Cheng was invited to deliver educational lecture for VIVA Education Webinar entitled Gut Microbiome and Effects of Cancer Therapy.